Genetic Clinics

Volume 13 | Issue 3 | July - September 2020

GeNeDit

July to September 2020| Vol 13 | Issue 3 | Page No 01

Hope in the Time of the Pandemic

'It was the best of times, it was the worst of times; it was the spring of hope, it was the winter of despair'. This opening phrase from 'The Tale of Two Cities' by Charles Dickens comes to mind, as we reflect on the sequence of events that have been unfolding across the world over the past few months

Dr. Prajnya Ranganath


GeNeViSTA

July to September 2020| Vol 13 | Issue 3 | Page No 06-12

Genetics of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disease with a rising trend of cases globally. While majority are polygenic in origin, monogenic forms account for 1-5 % of cases. Increased recognition of monogenic types is the outcome of a wider availability of molecular tests.

Dr Shubha R Phadke


GeNeViSTA

July to September 2020| Vol 13 | Issue 3 | Page No 13-26

Microdeletion and Microduplication Syndromes: An Update

Microdeletion and microduplication syndromes (MMS) also known as 'contiguous gene syndromes' are a group of disorders caused by sub-microscopic chromosomal deletions or duplications. Most of these conditions are typically associated with developmental delay, autism, multiple congenital anomalies,

Dr Prajnya Ranganath


GeNeXprESS

July to September 2020| Vol 13 | Issue 3 | Page No 27-28

Promising New Therapies for Genetic Disorders: Hope for a Brighter Future

Huntingtin (HTT)-lowering approaches with various genetic engineering techniques like genome editing, transcript targeting and protein targeting are current areas of research providing hope for a cure for Huntington disease (HD). A phase III clinical drug trial by Tabrizi et al. based

Dr Prajnya Ranganath


Heartoheartalk

July to September 2020| Vol 13 | Issue 3 | Page No 29-30

COVID 19 Times: Experiences and Learnings

The COVID19 pandemic has led to an unprecedented situation world-wide. Not only has it put people under lock-down, all businesses have come to a grinding halt leading to significant economic losses. It has claimed more than 400,000 lives and has infected as many as 7 million people worldwide

Chaitanya A Datar


PhotoQuiz

July to September 2020| Vol 13 | Issue 3 | Page No 30

This 30 years-old man presented with recurrent epistaxis and hemoptysis. Identify the condition

Dr Prajnya Ranganath


GeNeImage

1. Workflow for diagnostic testing of COVID 19

2. Genomic organization of SARS-COV-2 virus

Shubha R Phadke


Visitors Count:

Powered By: logo